Results 221 to 230 of about 90,478 (344)

Immediate Reconstruction of Pancretaticogastrostomy Following Hepatopancreatoduodenectomy for Biliary Tact Cancer: A Single‐Center Review of 33 Consecutive Patients

Annals of Gastroenterological Surgery, Volume 10, Issue 1, Page 187-196, January 2026.
This study showed that the pancreaticogastrostomy technique in HPD of biliary tract cancer reduced the incidence of pancreatic fistula from 45% to 12%. In‐hospital mortality was also reduced from 27% to 3%. ABSTRACT Background and Purpose Although hepatopancreaticoduodenectomy (HPD) is effective for margin‐negative curative resection of biliary tract ...
Ryusei Matsuyama, Yasuhiro Yabusita, Tomoaki Takahashi, Yutaro Kikuchi, Kouta Sahara, Kentaro Miyake, Yu Sawada, Yuuki Homma, Takafumi Kumamoto, Itaru Endo   +9 more
wiley   +1 more source

Preoperative serum prealbumin as a prognostic marker for survival after gallbladder cancer resection: a multicenter study. [PDF]

BMC Gastroenterol
Huang Z, Wang J, Zhou B, Liao R, Xu J, Guo P, Liu Z, You N, Tao R, Hu Q.   +9 more
europepmc   +1 more source

Systematic review: Should routine resection of the extra-hepatic bile duct be performed in gallbladder cancer?

, 2010
ParulJ Shukla, Savio George Barreto
openalex   +1 more source

Heparanase and gallbladder cancer: New insights into understanding tumor growth and invasion [PDF]

, 2008
Usha Dutta, Kuchhangi Sureshchandra Poornachandra   +1 more
openalex   +1 more source

Essential Updates 2023/2024: Minimally Invasive Surgery for Biliary Tract Cancer

Annals of Gastroenterological Surgery, Volume 10, Issue 1, Page 25-34, January 2026.
ABSTRACT Minimally invasive surgery (MIS) for biliary tract cancer (BTC) has gained traction with advancements in laparoscopic and robotic techniques. However, its oncological impact remains uncertain. This review highlights key studies from 2023 and 2024 on MIS for BTC, including distal bile duct, hilar bile duct, gallbladder, and intrahepatic bile ...
Osamu Itano, Takuya Minagawa
wiley   +1 more source

Anti-gallbladder cancer activities and toxicity studies of glycyrrhetinic acid derivative as a novel PPARγ agonist. [PDF]

Front Immunol
Liu M, Ma H, Xiong G, Qi M, Xia Y, Zhao Y, Ji C, Sun J, Sun T.   +8 more
europepmc   +1 more source

Efficacy of Sequential Hepatic Vein Embolization Following Portal Vein Embolization in Promoting Regeneration of Liver Volume and Function Before Right‐Sided Major Hepatectomy

Annals of Gastroenterological Surgery, Volume 10, Issue 1, Page 229-240, January 2026.
Sequential hepatic vein embolization (HVE) following portal vein embolization (PVE) significantly improves both the volume and function of the future remnant liver (FRL) compared to PVE alone. In this study, the FRL regeneration rates for volume and function were markedly higher and faster in the PVE–HVE group, with no differences in surgical outcomes ...
Thanh Tung Lai, Kosuke Matsui, Hideyuki Matsushima, Hidekazu Yamamoto, Gozo Kiguchi, Hisashi Kosaka, Van Khanh Nguyen, Yasuhiro Ueno, Shuji Kariya, Masaki Kaibori   +9 more
wiley   +1 more source

National Cancer Database analysis of gallbladder cancer: Evaluating survival benefit of chemotherapy in early-stage gallbladder cancer. [PDF]

World J Gastrointest Surg
Kim M, Vengatesan K, Aploks K, Thompson K, Dong X, Seshadri R.   +5 more
europepmc   +1 more source

An end-to-end interpretable machine-learning-based framework for early-stage diagnosis of gallbladder cancer using multi-modality medical data [PDF]

Haiying Zhao, Chuang Miao, Yidi Zhu, Yijun Shu, Xiangsong Wu, Ziming Yin, Xiao Deng, Wei Gong, Ziyi Yang, Weiwen Zou   +9 more
openalex   +1 more source

Potential Survival Benefit of Adjuvant Chemotherapy in Stage IV Intrahepatic Cholangiocarcinoma: A Multicenter, Stage‐Stratified Analysis

Annals of Gastroenterological Surgery, Volume 10, Issue 1, Page 241-250, January 2026.
This multicenter study suggests that adjuvant chemotherapy may improve survival in stage IV intrahepatic cholangiocarcinoma after resection, with S‐1 showing a potential survival advantage. ABSTRACT Background The survival benefit of adjuvant chemotherapy (AC) in intrahepatic cholangiocarcinoma (ICC) remains uncertain, particularly in advanced‐stage ...
Hisashi Kosaka, Masaki Ueno, Hiroji Shinkawa, Yusuke Yamamoto, Masahiko Kinoshita, Koji Komeda, Tsukasa Aihara, Satoshi Yasuda, Haruki Mori, Masaki Kaibori   +9 more
wiley   +1 more source